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Background -Surfactant protein A (SP-A) acts as an immune system modulator in the lungs and may therefore be involved in the pathogenesis of hypersensitivity pneumonitis. Methods -The levels of SP-A in bronchoalveolar lavage (BAL) fluid were measured in 20 subjects with acute farmer's lung, 16 asymptomatic dairy farmers, and 14 normal controls. Eight patients had a second evaluation after one month of treatment by either contact avoidance (n =3) or oral prednisolone (20 or 25 mg/day, n= 5). Chest radiographs and lung function measurements were also obtained in all farmers, twice in those re-evaluated after treatment.
Results -Patients with acute farmer's lung had significantly higher levels of SP-A than asymptomatic farmers and normal controls (p = 0.005) with mean (SE) values of 1.43 (0.29) ig/ml, 0.62 (0.09) tg/ml, and 0.68 (0.11) tg/ml, respectively. In eight subjects tested after one month of treatment the level of SP-A was unchanged although all were Surfactant protein A (SP-A), the major surfactant associated protein, has dual functions both in the maintenance of surface active properties of surfactant and as an immune system modulator.9"0 Specifically, SP-A is a chemotactic agent for alveolar macrophages, acts as an opsonin, and enhances phagocytosis of bacteria and viruses."-'3 Since farmer's lung is an immune response to a bacterial antigen and since alveolar macrophages are probably involved in the disease, a role for SP-A in hypersensitivity pneumonitis is certainly possible. 4 Guzman et al have shown that alveolar macrophages from patients with hypersensitivity pneumonitis have an increased content of SP-A. 4 The same group also showed in a small number of patients with hypersensitivity pneumonitis (mostly bird fancier's lung) that levels of SP-A in the bronchoalveolar lavage (BAL) fluid were increased.'5 These authors concluded that SP-A may not only be involved in the pathophysiology of hypersensitivity pneumonitis, but also that levels of this protein in the BAL fluid could be useful as a marker ofdisease activity in hypersensitivity pneumonitis and other interstitial lung diseases.
The present study was The data were expressed as mean (SE). To compare SP-A levels in asymptomatic farmers and subjects with farmer's lung with a control group a one-way ANOVA was performed and comparisons between groups were made using Tukey's approach. Estimates of the differences with their respective 95% confidence intervals are given in the results section. As normality and variance homogeneity assumptions were met, the F test estimate from original data was used. Comparisons between asymptomatic farmers and subjects with farmer's lung were performed using Student's t tests. Data from subjects with farmer's lung at diagnosis and after one month of treatment were analysed with Student's paired t tests. To measure relationships between SP-A levels and lung function measurements, radiological score, or cells in the BAL fluid, Spearman correlation coefficients were used. All reported p values were considered significant at the 0.05 level. The data were analysed using the statistical package program SAS (SAS Institute Inc, Cary, North Carolina, USA).
Results
Lung function data for asymptomatic farmers and patients with farmer's lung, both at diagnosis and after one month of treatment in eight subjects, are given in table 1 fig 1 and show improvement in lung infiltrations after one month of treatment in five of the seven patients. Although all subjects in the group of eight were improved after one month of treatment, the increase in lung TLCo and the decrease in radiographic scores did not reach statistical significance (p = 0.090 and 0.056, respectively).
The total cell numbers and differential cell counts for the three groups of subjects are given in fig 2. Cell counts before and after treatment for the eight subjects who had two evaluations are given in fig 3. The levels of SP-A in the BAL fluid of the three groups are given in fig 4 (table 2) . SP-A levels remained high after one month of treatment in the eight subjects with farmer's lung who were studied twice (fig 5) . No correlation was seen in this group The amount of inorganic phosphorus in the BAL fluid was similar for all groups of subjects including those lavaged after one month of treatment (fig 6) , indicating that concentrations of phospholipids were not increased in patients with hypersensitivity pneumonitis compared with asymptomatic farmers and healthy controls.
Discussion
As previously reported, these results show that farmer's lung is associated with a high intensity lymphocytic alveolitis and that some asymptomatic farmers have a moderate increase in BAL cells, especially lymphocytes.2 The lack of improvement in BAL cellularity after one month of treatment was also as previously reported.24
The results of this study show that SP-A levels in BAL fluid of patients with acute farmer's lung are increased compared with normal controls. Since the level of inorganic phosphorus was not increased in patients with acute farmer's lung, the increase in SP-A does not reflect an overall increase in surfactant but an increase in the SP-A/phospholipid ratio. These data confirm findings in other forms of hypersensitivity pneumonitis and, in addition, show that SP-A levels remain high after effective treatment of farmer's lung.'5 Although the number of subjects studied before and after treatment is small (n = 8), the lack of correlation between lung function, lung infiltrations, and the persistent increase in SP-A after either form of treatment does not support the hypothesis that SP-A levels in BAL fluid could be used as a marker of disease activity.
The lack of correlation between age and SP-A levels and the similarity in SP-A levels in the controls and asymptomatic farmers suggest that higher SP-A levels in patients with acute farmer's lung cannot be explained by the age difference between the groups.
Although SP-A has immunoregulatory functions, its exact role in farmer's lung remains phospholipid profile, as well as production of inflammatory cytokines following antigen challenge, can be counted either as a non-specific marker of epithelial dysfunction with parenchymal inflammation or as an additional contributor to the dysregulation of the cytokine network.32325
The persistence of high levels of SP-A in the BAL fluid after effective treatment suggests that SP-A is not a sensitive marker of disease improvement after one month of follow up. One possibility is that the increased SP-A level represents a defence mechanism with SP-A not being involved in the disease process but turned In conclusion, the present study shows that SP-A levels are increased in acute farmer's lung but suggests that this protein is not a clear marker of disease severity. The lack of increase of SP-A in asymptomatic bronchoalveolar lymphocytosis would indicate that SP-A is not involved in the altered immune modulation that allows the recruitment of lymphocytes in the lungs in hypersensitivity pneumonitis.
